Galcanezumab

Rapid Treatment Onset, Reduced Headache Days With Galcanezumab

Rapid Treatment Onset, Reduced Headache Days With Galcanezumab

By

In the post-hoc analysis, researchers evaluated the time to onset of effect of galcanezumab as well as whether treatment with the study drug was associated with a reduction in migraine headache days.

Monthly Subcutaneous Galcanezumab Effective for Migraine Prevention

Monthly Subcutaneous Galcanezumab Effective for Migraine Prevention

By

Monthly subcutaneous injections of galcanezumab at either 120 mg or 300 mg were effective for preventing migraines.

Episodic Migraines Possibly Prevented With Subcutaneous Galcanezumab

Episodic Migraines Possibly Prevented With Subcutaneous Galcanezumab

Researchers have found that monthly subcutaneous injection of galcanezumab significantly reduce migraine headache days.

Galcanezumab Monthly Injections Beneficial in Migraine Pain

Galcanezumab Monthly Injections Beneficial in Migraine Pain

By

Monthly galcanezumab injections at 120 mg or 240 mg offer clinical benefit in reducing migraine pain.

Sign Up for Free e-Newsletters